ABL is a global Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) that specializes in biotherapies, oncolytics, and viral vector vaccines. With a strong focus on biomanufacturing and immunology, ABL offers a wide range of services and products. Their services include cell-based assays, immunoassays, biomarkers, translational product development, and government partnering for the development of therapeutic biotechnology products.

ABL works closely with government agencies such as the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Disease (NIAID) to support research and development in areas like HIV prevention, neurological-related disorders, and cancer prevention. ABL's expertise extends to manufacturing and nonclinical studies, custom manufacturing of virus-based therapeutics, and fill/finish services for vaccine candidates. They collaborate with renowned organizations like the University Clinic of Tuebingen, Themis, and Just - Evotec Biologics for the development of innovative treatments.

With a dedicated team of experts and state-of-the-art facilities, ABL is committed to advancing research and finding breakthrough solutions in the field of biotechnology